Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

First Bioabsorbable Drug-Eluting Stent Implanted In Guidant Trial

This article was originally published in The Gray Sheet

Executive Summary

"It melts in your artery, not in your hand" might be an appropriate tag line for a next-generation stent product from Guidant that just entered clinical trials

You may also be interested in...



Bioabsorbable Stents Raise New Concerns For Investigators And Regulators

The next big thing in drug-eluting stents might be a simple disappearing act

Bioabsorbable Stents Raise New Concerns For Investigators And Regulators

The next big thing in drug-eluting stents might be a simple disappearing act

Weird Xience: Abbott Will Launch The Guidant Stent Before Boston Scientific

Boston Scientific plans to launch the Xience drug-eluting stent three months after the same stent is introduced by licensing partner Abbott, giving Abbott a short-term sales advantage

Related Content

UsernamePublicRestriction

Register

MT023313

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel